Related references
Note: Only part of the references are listed.NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease
Nicholas H. Varvel et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Fibrillar Amyloid-β Peptides Activate Microglia via TLR2: Implications for Alzheimer's Disease
Malabendu Jana et al.
JOURNAL OF IMMUNOLOGY (2008)
IL-4-Induced Selective Clearance of Oligomeric β-Amyloid Peptide1-42 by Rat Primary Type 2 Microglia
Eisuke Shimizu et al.
JOURNAL OF IMMUNOLOGY (2008)
Microglia lacking E prostanoid receptor subtype 2 have enhanced Aβ phagocytosis yet lack Aβ-activated neurotoxicity
FS Shie et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Rofecoxib - No effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study
SA Reines et al.
NEUROLOGY (2004)
Neurodegenerative disorders associated with diabetes mellitus
M Ristow
JOURNAL OF MOLECULAR MEDICINE-JMM (2004)
Modulation of nuclear factor-κB activity by indomethacin influences Aβ levels but not ap precursor protein metabolism in a model of Alzheimer's disease
S Sung et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Repression of IFN-γ expression by peroxisome proliferator-activated receptor γ
R Cunard et al.
JOURNAL OF IMMUNOLOGY (2004)
Yin and Yang: complement activation and regulation in Alzheimer's disease
Y Shen et al.
PROGRESS IN NEUROBIOLOGY (2003)
NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo
JL Eriksen et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Neuronal and glial coexpression of argininosuccinate synthetase and inducible nitric oxide synthase in Alzheimer disease
MT Heneka et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2001)
Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease
Y Matsuoka et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists - The Cache County Study
JC Anthony et al.
NEUROLOGY (2000)
Chronic overproduction of transforming growth factor-beta 1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice
T Wyss-Coray et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)